InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,465.17
(
0.11%
)
US TECH 100
18,564.40
(
0.25%
)
Dow Jones
40,561.72
(
-0.07%
)
Brent Oil
79.03
(
-1.92%
)
Bitcoin
67,427.25
(
-0.55%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Wednesday, 09/27/2006 8:03:46 PM

Wednesday, September 27, 2006 8:03:46 PM

Post# of 4764
Question for the board regulars. Is there precedent for bundling of pharmaceuticals by pharma/biotech companies (selling multiple products together at a discount rate)? Specifically, in the case of Amgen, would it be possible/legal to bundle Vectibix with Amgen’s supportive care onc products (EPO and Neupogen) or Amgen’s future onc products. Would such an arrangement legal? Would it violate any antitrust laws? Any comments would be greatly appreciated.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up